Predictive and prognostic value of circulating tumor cell detection in lung cancer: A clinician's perspective

被引:30
|
作者
Tognela, Annette [1 ,3 ,5 ,6 ]
Spring, Kevin J. [1 ,3 ,4 ]
Becker, Therese [1 ,3 ,4 ]
Caixeiro, Nicole J. [1 ,3 ]
Bray, Victoria J. [2 ]
Yip, Po Yee [6 ,7 ]
Chua, Wei [2 ,3 ]
Lim, Stephanie H. [1 ,2 ,3 ,4 ]
De Souza, Paul [1 ,2 ,3 ,4 ,5 ]
机构
[1] Ingham Inst Appl Med Res, Med Oncol Grp, Liverpool 2170, Australia
[2] Liverpool Hosp, Dept Med Oncol, Liverpool 2170, Australia
[3] South West Sydney Translat Canc Res Unit, Liverpool 2170, Australia
[4] Univ New S Wales, Sch Med, Kensington, NSW 2052, Australia
[5] Univ Western Sydney, Macarthur Clin Sch, Campbelltown, NSW 2560, Australia
[6] Campbelltown Hosp, Dept Med Oncol, Campbelltown, NSW 2560, Australia
[7] Univ Sydney, Sydney Med Sch, Camperdown, NSW 2006, Australia
关键词
Biomarkers; Non-small cell; Small cell; Circulating tumor cells; Lung cancer; POLYMERASE-CHAIN-REACTION; ASSISTED THORACIC-SURGERY; PULMONARY VENOUS-BLOOD; TRANSCRIPTION FACTOR-I; PERIPHERAL-BLOOD; MESSENGER-RNA; SURGICAL MANIPULATION; PROTEIN EXPRESSION; MOLECULAR-BIOLOGY; SURVIVAL;
D O I
10.1016/j.critrevonc.2014.10.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
There is increasing evidence for the use of circulating tumor cells (CTCs) as a "liquid biopsy" for early detection of lung cancer recurrence, prognosticating disease and monitoring treatment response. Further, CTC molecular analysis and interrogation of single cells hold significant potential in providing insights into tumor biology and the metastatic process. Ongoing research will likely see the translation of CTCs as a prognostic and predictive biomarker in both small cell, and non-small cell, lung cancer to routine clinical practice. Crown Copyright (C) 2014 Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:90 / 102
页数:13
相关论文
共 50 条
  • [41] Preoperative Circulating Tumor Cell Detection Using the Isolation by Size of Epithelial Tumor Cell Method for Patients with Lung Cancer Is a New Prognostic Biomarker
    Hofman, Veronique
    Bonnetaud, Christelle
    Ilie, Marius I.
    Vielh, Philippe
    Vignaud, Jean Michel
    Flejou, Jean Francois
    Lantuejoul, Sylvie
    Piaton, Eric
    Mourad, Nadine
    Butori, Catherine
    Selva, Eric
    Poudenx, Michel
    Sibon, Stephanie
    Kelhef, Sabrina
    Venissac, Nicolas
    Jais, Jean-Philippe
    Mouroux, Jerome
    Molina, Thierry Jo
    Hofman, Paul
    CLINICAL CANCER RESEARCH, 2011, 17 (04) : 827 - 835
  • [42] Prognostic and predictive value of tumor in early breast cancer
    Criscitiello, Carmen
    Esposito, Angela
    Trapani, Dario
    Curigliano, Giuseppe
    CANCER TREATMENT REVIEWS, 2016, 50 : 205 - 207
  • [43] Predictive and prognostic value of circulating endothelial cells in non-small cell lung cancer patients treated with standard chemotherapy
    Najjar, Fadi
    Alammar, Moosheer
    Bachour, Marroan
    Almalla, Nissreen
    Altahan, Moaz
    Alali, Ali
    Al-Massarani, Ghassan
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (01) : 119 - 125
  • [44] Prognostic and Predictive Value of Tumor Budding in Colorectal Cancer
    Mitrovic, Bojana
    Handley, Kelly
    Assarzadegan, Naziheh
    Chang, Hector Li
    Dawson, Heather A. E.
    Grin, Andrea
    Hutchins, Gordon G. A.
    Magill, Laura
    Quirke, Philip
    Riddell, Robert H.
    Gray, Richard G.
    Kirsch, Richard
    CLINICAL COLORECTAL CANCER, 2021, 20 (03) : 256 - 264
  • [45] Predictive and prognostic value of circulating endothelial cells in non-small cell lung cancer patients treated with standard chemotherapy
    Fadi Najjar
    Moosheer Alammar
    Marroan Bachour
    Nissreen Almalla
    Moaz Altahan
    Ali Alali
    Ghassan Al-Massarani
    Journal of Cancer Research and Clinical Oncology, 2015, 141 : 119 - 125
  • [46] Biological markers in lung cancer: A clinician's perspective
    Tufman, Amanda
    Huber, Rudolph Maria
    CANCER BIOMARKERS, 2010, 6 (3-4) : 123 - 135
  • [47] Prognostic and predictive value of circulating tumor DNA during neoadjuvant chemotherapy for triple negative breast cancer
    Luca Cavallone
    Adriana Aguilar-Mahecha
    Josiane Lafleur
    Susie Brousse
    Mohammed Aldamry
    Talia Roseshter
    Cathy Lan
    Najmeh Alirezaie
    Eric Bareke
    Jacek Majewski
    Cristiano Ferrario
    Saima Hassan
    Federico Discepola
    Carole Seguin
    Catalin Mihalcioiu
    Elizabeth A. Marcus
    André Robidoux
    Josée-Anne Roy
    Manuela Pelmus
    Mark Basik
    Scientific Reports, 10
  • [48] Prognostic and predictive value of circulating tumor cells in metastatic breast cancer patients treated with endocrine or chemotherapy
    Ellis, MJ
    Miller, MC
    Cristofanilli, M
    Budd, GT
    Stopeck, A
    Hayes, DF
    Doyle, GV
    Matera, J
    Terstappen, LWMM
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S7 - S7
  • [49] Exploring the prognostic and predictive value of circulating tumor DNA in patients with advanced colorectal cancer and chemotherapy.
    Liu, Xiu
    Zhang, Xuan
    Ou, Kai
    Lu, Chelong
    Zheng, Dong
    Liu, Jun
    Xu, Qiang
    Yang, Lin
    CANCER RESEARCH, 2021, 81 (13)
  • [50] Circulating Tumor DNA Is a Variant of Liquid Biopsy with Predictive and Prognostic Clinical Value in Breast Cancer Patients
    Zavarykina, Tatiana M.
    Lomskova, Polina K.
    Pronina, Irina V.
    Khokhlova, Svetlana V.
    Stenina, Marina B.
    Sukhikh, Gennady T.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (23)